Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

LoginID announces Partners integrating its FIDO-certified Strong Customer Authentication platform

Published

on

 

LoginID Inc. has announced new partnerships as part of its launch of FIDO-as-a-Service, for small and medium sized enterprises.  This follows on its recent announcement for the Indonesian market, with eKYC leader, ASLI RI. The new partners announced will integrate the LoginID FIDO2 and UAF certified biometric strong customer authentication in support of various use-cases.

By integrating the LoginID strong customer authentication, partners will now be able to reduce end-user dependency on weak logins and passwords.  According to the FIDO Alliance, 64% of eCommerce customers and 78% of peer to peer transfer users, prefer stronger authentication versus traditional logins and passwords.  With LoginID’s FIDO-as-a-Service, partners will be able to provide their customers additional confidence, and higher security in their daily digital interactions, eliminating passwords and logins.  “Developers and enterprises are looking for very low-lift integrations of leading-edge products. Our FIDO2 and UAF certified strong customer authentication can be integrated in less than an hour, and will provide end-users a frictionless experience” says Simon Law, CEO of LoginID.

Differing from proprietary biometric solutions, the LoginID FIDO2 and UAF certified platform utilizes cryptographic security based on the customer’s device hardware, therefore it is not vulnerable to hacks or OS takeovers.  It works right out of the box, with no additional hardware or downloadable software required by customers.  The customer experience is very simple and intuitive, with a ‘biometric login’ button displayed, where customers can use their fingerprint scanner on their device to login to an application or website.  Customers won’t have to remember passwords or use other weaker forms of logging in.

Data on Tap is a Canadian based telecom technology company that is developing a digital ecosystem of highly-customized mobile services serving smartphone customers.  “With the LoginID FIDO2 service we will be able to increase digital in-app and web interactions security and where required provide additional authentication and user level control,” says Algis Akstinas, CEO of Data on Tap.  “This will also alleviate any customer concerns around SIM swap attacks, which is becoming more of a prevalent issue for customers”.

Execuvault is a Toronto-based FinTech Startup on a mission to transform the legacy transfer process using blockchain technology. Self-executing smart contracts record the terms of users’ directives and bequests (assets, investments, life insurance policies, and documents— securely stored in a personalized vault); and then validate the criteria for assignment and disbursement. The XV Legacy Transfer Platform automates the division of funds through trusted transactions —which are digitally notarized and irrefutable— and can be carried out among disparate, anonymous parties; without the need for a central authority or external enforcement mechanism.   “We see a lot of flexibility around how we can easily integrate FIDO2 biometrics into our existing customer experience with LoginID” says Brian Kieller, CEO of ExecuVault.

NetCents Technology (CSE: N.C. / Frankfurt: 26N / OTCQB: NTTCF) provides a very simple way for merchants to accept cryptocurrency as a payment option for their customers. By integrating the NetCents crypto payment button, merchants have an easy way to process various cryptocurrencies and as a complement to traditional payment methods.  “Security is top of mind for our merchants and their clients.  Anything we can do to help further secure out interactions with our merchants or their customers, will help increase our future transaction volume,” says Pat Albright, Executive Vice President at NetCents Technology.

FroogalPay is middleware that provides software developers a quick and easy way to accept payments from within their application.  “Our clients not only need the highest standard around security, but we need to ensure that we provide ways to increase conversions.  With LoginID’s FIDO2 biometric button, there are various ways merchants can integrate into their customer journeys, making it simpler and safer for customers to pay while protecting merchants from fraud.” says Jonathan Reinsdorf, CEO of FroogalPay.

Global Asset Technology has developed an asset based crypto token that can be used towards traditional assets.  “With LoginID we will secure our interactions for our institutional clients, who need simple, yet rigorous security that eliminates threats to their accounts from outside parties” says Steve Katmarian, CEO of Global Asset Technology.

POS Connect is a software developer and payment processor which provides merchants and enterprises secure ways to bill and collect payments.  “More and more of our services are global in nature.  Since the FIDO standard is aligned with regulatory standards such as PSD2 and GDPR, our clients will have assurances that services they are providing meet the expectations of the market as it relates to security and privacy” says Marius Kimel, CEO of POS Connect.

Simon Law, CEO of LoginID says “These partners provide a great cross section of the types of businesses that can leverage strong customer authentication by integrating a simple, biometric button.  We expect to see more and more companies like these recognizing how easy it is to protect their customers while at the same time improving the overall experience.”

LoginID will be adding more functions and features for partners and developers as part of its self-serve digital onboarding experience, in the coming weeks.

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending